Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Key Statistics
26 reported figures for Kahira Pharmaceuticals & Chemical Industries Co. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 8.93B
- P/E (trailing)
- 16.16
- P/B
- 6.9
- Dividend yield (FY 2019)
- 0.33%
Income (latest fiscal year)
- Revenue
- EGP 2.52B
- Net income
- EGP 552.54M
- EBITDA
- EGP 726.25M
- Free cash flow
- EGP 377.39M
- Profit margin
- 21.95%
Balance sheet
- Total assets
- EGP 2.26B
- Total debt
- EGP 215.83M
- Book value
- EGP 1.29B
Growth
- Revenue growth
- 161.47%
- Profit growth
- 548.75%
- EPS growth
- 548.74%
Per share
- EPS (fiscal year)
- 37
- Book value per share
- 86.66
- Dividend per share
- 2
- Return on equity
- 42.69%
- Return on assets
- 24.5%
Technical
- RSI (14)
- 59.2
- 50-day moving average
- EGP 564.27
- 200-day moving average
- EGP 388.74
- Beta (1Y)
- 0.14
Shares
- Shares outstanding
- 14.93M
- Free float
- 30%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.